2015
DOI: 10.20510/ukjpb/3/i6/87835
|View full text |Cite
|
Sign up to set email alerts
|

aPTT: 1st Recognition for Human Whole Blood on QCM-D Platform

Abstract: Activated partial thromboplastin time (aPTT) assay for whole blood on quartz crystal microbalance with dissipation (QCM-D) platform has been recognized for the first time. QCM-D platform is studied in parallel with 'gold standard' mechanical coagulometer in the perspective of anticoagulant bio-sensing. In this report, the lowest sample volume application of 1.66 µL of human whole blood for aPTT has been demonstrated. Mechanical coagulomter uses 60 times higher whole blood (and each reagent) volume application … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…The resonant frequency of the BAW transducer is sensitive to the small mass addition on the upper surface or the change in the viscosity of adjacent mediums. QCM devices have been successfully used to monitor the blood coagulation in real time [ 9 ] and measure several hemostatic parameters, including activated partial thromboplastin time (aPTT) [ 10 ], prothrombinase induced clotting time (PiCT) [ 11 ], thrombin times (TTs) [ 12 ], prothrombin time (PT) [ 13 ] and fibrinogen [ 14 ]. This technology shows an outstanding application prospect in the point-of-care (POC) system.…”
Section: Introductionmentioning
confidence: 99%
“…The resonant frequency of the BAW transducer is sensitive to the small mass addition on the upper surface or the change in the viscosity of adjacent mediums. QCM devices have been successfully used to monitor the blood coagulation in real time [ 9 ] and measure several hemostatic parameters, including activated partial thromboplastin time (aPTT) [ 10 ], prothrombinase induced clotting time (PiCT) [ 11 ], thrombin times (TTs) [ 12 ], prothrombin time (PT) [ 13 ] and fibrinogen [ 14 ]. This technology shows an outstanding application prospect in the point-of-care (POC) system.…”
Section: Introductionmentioning
confidence: 99%
“…Biological approaches consider rising antibodies allowing topological recognitions of different HS/heparin domains, although the specificity of particular sequence recognition at the structural level is still far to be reached at sufficient levels . Among functional approaches, heparin—the most used anticoagulant in surgery—is controlled via anticoagulant standard tests such as thromboplastin time and activated partial thromboplastin time for proper therapeutic outcomes . Thus, although important advances keep ongoing, development of new approaches capable to detect specific HS/heparin fractions or sequences is still required.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, MIPs have been generated for a wide range of applications, including chromatography, solid‐phase extraction, reaction catalysis, and biomimetic sensors . Particularly, recognition of heparin by molecularly imprinted surfaces has been introduced by Hussain and co‐workers . However, approaches allowing recognition of particular sulfated sequences in HS and/or heparin remain to be developed.…”
Section: Introductionmentioning
confidence: 99%
“…QCM is well known due to its cost-effectiveness for biosensor applications on comparing to its counterpart sensor techniques 14 . Recently, haemostasis [15][16][17][18][19][20] Technoclone gmbH (Austria).…”
Section: Introductionmentioning
confidence: 99%